Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
COBENFY (xanomeline-trospium), marketed as KarXT, is a first-in-class antipsychotic therapy offering a novel approach to managing schizophrenia in adults. The combination of xanomeline—a muscarinic receptor agonist—and trospium—a peripheral anticholinergic—enables central therapeutic action with minimized peripheral side effects. This dual-action strategy helps reduce hallucinations, delusions, and other psychotic symptoms while preserving cognitive function. Individuals considering whether to buy COBENFY can expect a non-dopaminergic treatment option designed for both efficacy and tolerability.
| Fact Table | |
|---|---|
| Formula | Xanomeline: C21H23NO · Trospium: C25H30NO3Cl |
| License | FDA approved (2024) |
| Bioavailability | Xanomeline: ~5–10%; Trospium: <10% (oral) |
| Legal status | Prescription only |
| Chemical Name | Xanomeline-trospium |
| Elimination half-life | Xanomeline: ~4 hours; Trospium: ~20 hours |
| Dosage (Strength) | 50 mg xanomeline / 20 mg trospium (administered twice daily) |
| Pregnancy | Consult doctor – limited human data available |
| Brands | COBENFY |
| Protein binding | Xanomeline: Not well defined; Trospium: ~50% |
| PubChem CID | Xanomeline: 60945 · Trospium: 72006 |
| MedlinePlus | Not listed |
| ChEBI | Xanomeline: CHEBI:76151 · Trospium: CHEBI:9455 |
| ATC code | N05AX33 |
| DrugBank | Xanomeline: DB12936 · Trospium: DB00332 |
| KEGG | Xanomeline: D08666 · Trospium: D08754 |
| Routes of administration | By mouth (oral tablets) |
The dosing of COBENFY should be individualized and initiated under the supervision of a licensed prescriber. It typically begins with a dose titration to evaluate tolerability, then proceeds to a stable maintenance dose. Administration can occur with or without meals, and it is essential to maintain a regular dosing schedule to achieve maximum benefit. Patients should not alter their dose unless advised by their doctor.
COBENFY includes two active pharmacologic components:
Together, these agents create a synergistic mechanism that separates therapeutic action from side effect liability.
Monitoring is recommended in patients with preexisting bladder, gastrointestinal, or cardiovascular conditions. Elderly patients and those with neurocognitive disorders should be closely observed for signs of anticholinergic toxicity. For those concerned about COBENFY cost, affordability programs or insurance coverage may be available—patients are encouraged to consult with a healthcare provider or pharmacist.
COBENFY should not be used in patients with a known allergy to either active ingredient or in those with severe kidney disease or untreated narrow-angle glaucoma. It is also not recommended for use with other medications possessing strong anticholinergic activity unless clinically justified.
Potential adverse effects may include:
Severe or unusual reactions should be addressed promptly with a healthcare professional.
What is COBENFY?
COBENFY is a prescription medicine that contains xanomeline and trospium. It’s used to treat symptoms of schizophrenia in adults.
How does COBENFY work?
It combines xanomeline, which affects certain brain receptors involved in thinking and mood, with trospium, which reduces side effects outside the brain.
What symptoms does COBENFY help with?
COBENFY helps reduce symptoms like hallucinations, delusions, disorganized thinking, and social withdrawal in people with schizophrenia.
How is COBENFY taken?
COBENFY is usually taken by mouth twice a day, with or without food. Follow your healthcare provider’s instructions closely.
What are common side effects of COBENFY?
Some common side effects include nausea, constipation, dry mouth, and indigestion. Not everyone experiences these.
Who should not take COBENFY?
People with certain medical conditions, such as untreated narrow-angle glaucoma or urinary retention, should not take COBENFY. Always discuss your full medical history with your doctor.
Can COBENFY be taken with other medications?
Some medications may interact with COBENFY. Always tell your doctor and pharmacist about all drugs and supplements you're taking.
How long does it take for COBENFY to work?
Some people may notice improvement in symptoms within a few weeks, but full effects can take longer. Consistency is important.
What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. If it's close to your next dose, skip the missed one. Don’t double up.
Can I stop taking COBENFY suddenly?
Do not stop taking COBENFY without your doctor’s guidance, as symptoms could return or worsen.
